aspirin has been researched along with enalapril in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (34.48) | 18.2507 |
| 2000's | 19 (32.76) | 29.6817 |
| 2010's | 19 (32.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Cha, SH; Endou, H; Kanai, Y; Nakajima, N; Sekine, T; Tsuda, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hall, D; Rudolph, W; Zeitler, H | 1 |
| Buja, LM; Casscells, SW; Goff, DC; Gould, KL | 1 |
| Giles, TD | 1 |
| Dietz, R; Nagel, F; Osterziel, KJ | 1 |
| Agostoni, P; Cattadori, G; Guazzi, M; Lauri, G; Melzi, G | 1 |
| Agostoni, P; Alimento, M; Contini, M; Guazzi, M; Marenzi, G | 1 |
| Aursnes, I; Kjekshus, J; Nguyen, KN | 1 |
| Alimento, M; Campodonico, J; Celeste, F; Guazzi, M; Rossi, M; Santambrogio, G; Trabattoni, D | 1 |
| Coats, AJ | 1 |
| Agostoni, P; Guazzi, M; Melzi, G | 1 |
| Alimento, M; Campodonico, J; Celeste, F; Guazzi, M; Guazzi, MD; Rossi, M; Santambrogio, G; Trabattoni, D | 1 |
| Benhamda, K; Cador, R; Charbonnier, B; Cohen-Solal, A; Juillière, Y; Kromer, EP; Spaulding, C; Weber, S | 1 |
| Battler, A; Behar, S; Boyko, V; Goldbourt, U; Gottlieb, S; Leor, J; Reicher-Reiss, H | 1 |
| Block, A; Graves, T; Hauck, C; Katz, SD; LeJemtel, TH; Radin, M | 1 |
| Agostoni, P; Guazzi, M; Pontone, G | 1 |
| Ferguson, JJ | 1 |
| Cirigliano, MD; Nawarskas, JJ; Spinler, SA; Townsend, RR | 1 |
| Gavaghan, BJ; Kittleson, MD; McAloose, D | 1 |
| Guazzi, M | 1 |
| Barbash, IM; Behar, S; Goldbourt, U; Gottlieb, S; Leor, J | 1 |
| Brodskaia, SA; Ivanov, SN; Savenkov, MP | 1 |
| Przewłocka-Kosmala, M | 1 |
| Bergmann, JF; Caulin, C; Cohen-Solal, A; Habib, A; Jondeau, G; Kevorkian, JP; Knellwolf, AL; Lebret, M; Levy, B; Mahé, I; Meune, C; Mourad, JJ; Simoneau, G | 1 |
| Baiano, A; de Cristofaro, A; Del Forno, D; Giallauria, F; Paragliola, T; Rossi, M; Vigorito, C | 1 |
| Akula, A; Veeravalli, KK | 1 |
| Abbate, AF; Cingolani, OH; Di Gennaro, FP; Toblli, JE; Vilches, A | 1 |
| Kakishita, M; Nakamura, K; Ohe, T; Yamanari, H | 1 |
| Incorvaia, C; Pravettoni, C; Riario-Sforza, GG | 1 |
| Bauriedel, G; Lüderitz, B; Nickenig, G; Schneider-Schmitt, M; Skowasch, D; Viktor, A | 1 |
| Camargo, EG; Gross, JL; Lavinsky, J; Silveiro, SP; Weinert, LS | 1 |
| Doane, CJ; Gigliotti, A; Lammey, ML; Lee, DR; Sleeper, MM | 1 |
| Altamura, N; Consoloni, L; Dapas, B; Farra, R; Fiotti, N; Giacca, M; Giansante, C; Grassi, G; Moretti, M; Wassermann, S; Zacchigna, S | 1 |
| Bartsch, DK; Buchholz, M; Chen, NM; Feldmann, G; Fendrich, V; Maitra, A; Neef, M; Slater, EP; Waldmann, J | 1 |
| Hawk, E; Patterson, S | 1 |
| Aslani, A; Cheng, KK; Gharravi, M; Khoshnia, M; Larijani, B; Malekzadeh, F; Malekzadeh, R; Marshall, T; Nateghi, A; Pourshams, A; Rastegarpanah, M; Salahi, R; Semnani, S; Thomas, GN | 1 |
| Chia, PL; Lee, E | 1 |
| He, L; Lee, J; Mendell-Harary, J; Tao, B; Walker, J; Wickremasingha, P; Wight, D | 1 |
| Baier, A; Bartsch, DK; Fendrich, V; Holler, JP; Lopez, CL; Manoharan, J; Maschuw, K; Ramaswamy, A; Waldmann, J; Wichmann, S | 1 |
| Cheng, KK; Etemadi, A; Hemming, K; Jaafari, E; Khoshnia, M; Majed, M; Malekzadeh, F; Malekzadeh, R; Marjani, H; Marshall, T; Merat, S; Mohammadifard, N; Naemi, M; Nateghi, A; Navabakhsh, B; Ostovaneh, MR; Pourshams, A; Poustchi, H; Sadeghi, M; Sarrafzadegan, N; Thomas, GN | 1 |
| Agostoni, P; Apostolo, A; Camera, M; Cattadori, G; Compagnino, E; Contini, M; Farina, S; Fiorentini, C; Gertow, K; Magrì, D; Palermo, P; Tremoli, E | 1 |
| Carrara, A; Conte, D; Occhipinti, V; Orlando, S; Segato, S | 1 |
| Apola, A; Hubicka, U; Kwiecień, A; Maślanka, A; Opoka, W; Stolarczyk, M | 1 |
| Krawczeski, CD; Kwiatkowski, DM; Montez-Rath, ME; Sutherland, SM; Uber, AM | 1 |
| Albers, MB; Bartsch, DK; Bertolino, P; Bollmann, C; Di Fazio, P; Fendrich, V; Joos, B; Lopez-Lopez, CL; Manoharan, J; Mintziras, I; Ramaswamy, A; Roth, S; Slater, EP; Zhang, CX | 1 |
| Singh, A; Tafoya, C | 1 |
| Boffetta, P; Brennan, P; Cheng, KK; Etemadi, A; Fazel, A; Gharavi, A; Hemming, K; Kamangar, F; Khoshnia, M; Majed, M; Malekzadeh, F; Malekzadeh, R; Marshall, T; Merat, S; Mohammadifard, N; Naemi-Tabiei, M; Nalini, M; Nateghi, A; Navabakhsh, B; Ostovaneh, MR; Pourshams, A; Poustchi, H; Roshandel, G; Sadeghi, M; Sarrafzadegan, N; Thomas, N | 1 |
4 review(s) available for aspirin and enalapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
Aspirin and ACE-inhibitors: for wedding or funeral?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Case-Control Studies; Clinical Trials as Topic; Drug Interactions; Enalapril; Evidence-Based Medicine; Heart Failure; Hemodynamics; Models, Animal; Multicenter Studies as Topic; Myocardial Ischemia; Prostaglandin Antagonists; Prostaglandins; Pulmonary Circulation; Renal Circulation; Safety; Vasodilation; Vasodilator Agents | 2001 |
Cardiac Memory: A Case Report and Review of the Literature.
Topics: Aged; Amlodipine; Arrhythmias, Cardiac; Aspirin; Bundle-Branch Block; Chest Pain; Electrocardiography; Emergency Service, Hospital; Enalapril; Headache; Heart Ventricles; Humans; Isosorbide Dinitrate; Male; Nausea; Nitroglycerin; Platelet Aggregation Inhibitors; Vasodilator Agents; Vomiting | 2019 |
18 trial(s) available for aspirin and enalapril
| Article | Year |
|---|---|
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
Topics: Adult; Aged; Aspirin; Chi-Square Distribution; Chronic Disease; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Pulmonary Circulation; Pulmonary Wedge Pressure; Renin; Severity of Illness Index; Vascular Resistance | 1992 |
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Renal Circulation | 1994 |
[Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Enalapril; Exercise Tolerance; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Respiration; Respiratory Function Tests | 1996 |
Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood-Air Barrier; Bradykinin; Cyclooxygenase Inhibitors; Diffusion; Double-Blind Method; Enalapril; Epoprostenol; Exercise Test; Female; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Pulmonary Circulation; Pulmonary Gas Exchange; Respiratory Function Tests | 1997 |
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cause of Death; Confidence Intervals; Double-Blind Method; Drug Interactions; Enalapril; Female; Follow-Up Studies; Forecasting; Heart Failure; Humans; Logistic Models; Male; Myocardial Infarction; Placebos; Recurrence; Retrospective Studies; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1997 |
[The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Drug Interactions; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation Inhibitors; Prostaglandins | 1997 |
Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Cardiomyopathy, Dilated; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Pulmonary Diffusing Capacity; Pulmonary Ventilation; Respiratory Mechanics | 1997 |
Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Double-Blind Method; Enalapril; Female; Hemodynamics; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Coronary Disease; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Israel; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Risk Factors; Survival Rate | 1999 |
Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with Enalapril. Ifetroban Study Group.
Topics: Aged; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Enalapril; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Muscle, Skeletal; Oxazoles; Platelet Aggregation Inhibitors; Plethysmography; Regional Blood Flow; Vasodilator Agents | 1999 |
Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Blood Pressure; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Patient Compliance; Thromboxane B2 | 1999 |
[Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Drug Antagonism; Enalapril; Female; Humans; Hypertension; Ibuprofen; Indomethacin; Lisinopril; Male; Middle Aged; Osteochondritis | 2001 |
[High doses of aspirin reduce natriuresis in hypertensive patients treated with enalapril].
Topics: Adult; Aged; Antihypertensive Agents; Aspirin; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Natriuresis; Platelet Aggregation Inhibitors; Prospective Studies | 2004 |
The effect of aspirin on the antiproteinuric properties of enalapril in microalbuminuric type 2 diabetic patients: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Enalapril; Female; Humans; Male; Middle Aged; Proteinuria | 2007 |
Short term effects of doxycycline on matrix metalloproteinases 2 and 9.
Topics: Adult; Anti-Bacterial Agents; Aspirin; Cell Degranulation; Doxycycline; Enalapril; Female; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neutrophils; Nitrates; Time Factors | 2009 |
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Chronic Disease; Double-Blind Method; Drug Combinations; Enalapril; Female; Heptanoic Acids; Humans; Hydrochlorothiazide; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Pyrroles; Risk Factors; Tablets | 2010 |
Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Clinical Protocols; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Male; Middle Aged; Polypharmacy; Primary Prevention; Research Design; Secondary Prevention; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; Valsartan | 2015 |
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Valsartan | 2019 |
36 other study(ies) available for aspirin and enalapril
| Article | Year |
|---|---|
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver.
Topics: Animals; Blotting, Northern; Carrier Proteins; Ion Transport; Liver; Membrane Proteins; Organic Anion Transporters, Sodium-Independent; Rats; Salicylates; Salicylic Acid; Substrate Specificity; Xenopus laevis | 1998 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Non-invasive management of coronary artery disease. Report of a meeting at the University of Texas Medical School at Houston.
Topics: Aged; Anticholesteremic Agents; Aspirin; beta Carotene; Carotenoids; Cholesterol, Dietary; Coronary Disease; Diet, Fat-Restricted; Diltiazem; Drug Therapy, Combination; Enalapril; Humans; Lovastatin; Male; Simvastatin; Tomography, Emission-Computed; Vitamins | 1995 |
Enalapril, aspirin interaction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Drug Interactions; Enalapril; Hemodynamics; Humans | 1997 |
Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Blood Pressure; Drug Administration Schedule; Drug Antagonism; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Middle Aged; Natriuresis; Severity of Illness Index | 1998 |
Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cyclooxygenase Inhibitors; Drug Interactions; Enalapril; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Gas Exchange; Spirometry | 1999 |
Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.
Topics: Abciximab; Alanine; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Benzamidines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Disease; Dalteparin; Defibrillators, Implantable; Double-Blind Method; Enalapril; Endothelial Growth Factors; Fatty Acids, Omega-3; Guanidines; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Laser Therapy; Lymphokines; Metoprolol; Multicenter Studies as Topic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Pyrrolidines; Randomized Controlled Trials as Topic; Simvastatin; Sodium-Hydrogen Exchangers; Stents; Sulfones; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E | 1999 |
Persistent atrial standstill in a cat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Cardiomegaly; Cat Diseases; Cats; Chylothorax; Diuretics; Echocardiography, Doppler, Color; Electrocardiography; Electrophysiology; Enalapril; Fatal Outcome; Female; Furosemide; Heart Atria; Lameness, Animal; Myocardium; Radiography, Thoracic; Recurrence | 1999 |
Hemodynamic interaction of aspirin with enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Enalapril; Heart Failure; Hemodynamics; Humans; Platelet Aggregation Inhibitors; Research Design; Ticlopidine | 1999 |
[The effect of acetylsalicylic acid on hypotensive action of enalapril in hypertensive patients].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Time Factors; Treatment Outcome | 2002 |
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arteries; Aspirin; Blood Pressure; Chronic Disease; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diastole; Dose-Response Relationship, Drug; Enalapril; Endpoint Determination; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Manometry; Middle Aged; Observer Variation; Prospective Studies; Ramipril; Renin; Reproducibility of Results; Single-Blind Method; Systole; Thromboxane B2; Time Factors; Treatment Outcome | 2003 |
[Cardiac rehabilitation in a HIV-patient treated with protease inhibitors].
Topics: Adult; Aspirin; Carbazoles; Carvedilol; Cholesterol; Coronary Angiography; Diet Therapy; Drug Therapy, Combination; Enalapril; Exercise Therapy; HIV Infections; Humans; Male; Myocardial Infarction; Nitrates; Pravastatin; Propanolamines; Protease Inhibitors; Treatment Outcome; Triglycerides | 2003 |
Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.
Topics: Animals; Aspirin; Bradykinin; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Injections, Intravenous; Lisinopril; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Peptides; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazolium Salts | 2004 |
Effects of cyclooxygenase inhibition on endothelial function in hypertensive patients treated with angiotensin-converting enzyme inhibitors.
Topics: Administration, Sublingual; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Cyclooxygenase Inhibitors; Dihydropyridines; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nitrobenzenes; Nitroglycerin; Piperazines; Platelet Aggregation Inhibitors; Regional Blood Flow; Vasodilator Agents | 2004 |
Urticaria-angioedema reaction caused by propafenone.
Topics: Angioedema; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Drug Hypersensitivity; Enalapril; Female; Humans; Hypertension; Middle Aged; Propafenone; Urticaria | 2006 |
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
Topics: Adenosine Diphosphate; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cardiovascular Diseases; Clopidogrel; Collagen; Coronary Artery Disease; Electric Impedance; Enalapril; Female; Fibrinolytic Agents; Germany; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Ticlopidine; Treatment Outcome | 2006 |
Diagnosis and treatment of pulmonary arterial hypertension and atrial fibrillation in an adult chimpanzee (Pan troglodytes).
Topics: Animals; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Diuretics; Enalapril; Furosemide; Hypertension, Pulmonary; Liver; Lung; Male; Myocardium; Pan troglodytes; Platelet Aggregation Inhibitors; Primate Diseases | 2008 |
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.
Topics: Amylases; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Aspirin; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Enalapril; Gene Expression Regulation, Neoplastic; Mice; Mice, Transgenic; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1 | 2010 |
Modelling a dream: the molecular prevention of pancreatic cancer.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Humans; Mice; Pancreatic Neoplasms | 2010 |
Reverse Takotsubo pattern stress cardiomyopathy in a male patient induced during dobutamine stress echocardiography.
Topics: Aspirin; Bisoprolol; Cardiomyopathies; Cardiotonic Agents; Chest Pain; Dobutamine; Echocardiography, Stress; Enalapril; Humans; Male; Middle Aged; Simvastatin | 2012 |
Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.
Topics: Adolescent; Adult; Allylamine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticonvulsants; Antihypertensive Agents; Area Under Curve; Aspirin; Atenolol; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Drug Interactions; Enalapril; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Phenytoin; Pyrazines; Rosiglitazone; Sitagliptin Phosphate; Thiazolidinediones; Tissue Distribution; Triazoles; Young Adult | 2014 |
Enalapril and ASS inhibit tumor growth in a transgenic mouse model of islet cell tumors.
Topics: Adenoma, Islet Cell; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cyclooxygenase Inhibitors; Disease Models, Animal; Enalapril; Female; Humans; Male; Mice, Transgenic; Middle Aged; NF-kappa B; Receptor, Angiotensin, Type 1; Tumor Burden; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Enalapril; Exercise Test; Female; Genotype; Heart Failure; Humans; Lung; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Respiratory Function Tests | 2016 |
ERCP or NO ERCP: the case report of a frail patient.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzodiazepines; Bisoprolol; Bronchodilator Agents; Diuretics; Emergency Service, Hospital; Enalapril; Fluticasone; Frail Elderly; Furosemide; Humans; Male; Nordazepam; Pain Management; Pancreatitis; Pantoprazole; Salmeterol Xinafoate; Thyroxine; Tomography, X-Ray Computed; Ultrasonography | 2018 |
Simultaneous Determination of Acetylsalicylic Acid, Hydrochlorothiazide, Enalapril, and Atorvastatin in a Polypill-Based Quaternary Mixture by TLC.
Topics: Aspirin; Atorvastatin; Cardiotonic Agents; Chromatography, Thin Layer; Densitometry; Drug Compounding; Enalapril; Hydrochlorothiazide; Limit of Detection; Reproducibility of Results | 2018 |
Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
Topics: Acute Kidney Injury; Adolescent; Aspirin; Cardiac Surgical Procedures; Child; Child, Preschool; Critical Illness; Enalapril; Female; Heart Defects, Congenital; Humans; Ibuprofen; Infant; Ketorolac; Male; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Vancomycin | 2018 |
Chemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model.
Topics: Animals; Aspirin; Chemoprevention; Enalapril; Mice; Mice, Knockout; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Pancreatic Neoplasms; Proto-Oncogene Proteins | 2018 |